Perceptions Of Cancer Care

How will the general public feel regarding current cancer treatment? this is often the question that the Lilly medicine network, PACE (Patient Access to Cancer care Excellence), tried to answer through a survey of the final public, cancer patients and caregivers. The results from their international survey are going to be printed within the open access journal ecancermedicalscience, the journal from the IEO and OECI.

Phone calls and on-line questionnaires were accustomed survey over four,300 people from six countries: the u.  s., France, Germany, Italy, Japan and therefore the uk. queries ranged from personal issues following a diagnosing of cancer to opinions on the price of cancer medicines/treatments.


Although there have been massive variations between countries, some trends were determined. 1/2 the respondents felt happy with the progress that has been created in cancer care within the past twenty years, with higher levels of satisfaction being displayed by patients and caregivers as compared to the final public. Similarly, simply thirty first of the final public responders felt assured within the care provided by their health care systems whereas patients reportable a fifty four level of satisfaction. once asked regarding unmet desires in cancer care, monetary impact and navigating treatment choices lidded the list.

The survey additionally discovered some misconceptions around cancer care. several respondents weren't awake to the character of cancer (is it one illness or many alternative types?) and lots of additionally underestimated each the time and prices involved the event of cancer medicines. Despite this estimation, a majority of respondents felt that a lot of ought to be endowed in developing new medicines and coverings which they must be created on the market even quicker. This urgency highlights the importance and priority cancer treatment received from several respondents. Another noted categorization concerned clinical trials. whereas most members of the final public would be willing to participate during a run if they were diagnosed with cancer, it had been found that only a few patients really participate in trials for variety of various reasons, together with inconvenience and prices.

The PACE cluster has referred to as these baseline results the 'PACE Cancer Perceptions Index (2012)', and believes that these findings can function a helpful place to begin for future surveys. They hope the results can facilitate to clarify patient attitudes, desires and priorities for stakeholders.